Cochrane Abstracts
Combined aclidinium bromide and long‐acting beta2‐agonist for chronic obstructive pulmonary disease (COPD)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Combined Aclidinium Bromide and Long‐acting Beta2‐agonist for Chronic Obstructive Pulmonary Disease (COPD)." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435321/all/Hydralazine_for_essential_hypertension:_Cochrane_systematic_review. Accessed 18 April 2024.
Combined aclidinium bromide and long‐acting beta2‐agonist for chronic obstructive pulmonary disease (COPD). Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435321/all/Hydralazine_for_essential_hypertension:_Cochrane_systematic_review. Accessed April 18, 2024.
Combined aclidinium bromide and long‐acting beta2‐agonist for chronic obstructive pulmonary disease (COPD). In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435321/all/Hydralazine_for_essential_hypertension:_Cochrane_systematic_review
Combined Aclidinium Bromide and Long‐acting Beta2‐agonist for Chronic Obstructive Pulmonary Disease (COPD) [Internet]. In: Cochrane Abstracts. [cited 2024 April 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435321/all/Hydralazine_for_essential_hypertension:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Combined aclidinium bromide and long‐acting beta2‐agonist for chronic obstructive pulmonary disease (COPD)
ID - 435321
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435321/all/Hydralazine_for_essential_hypertension:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
